Clinical Trial

Novel Biomarkers of Non-IgE Immediate Hypersensitivity Drug Reactions

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to investigate biomarkers of non-IgE-mediated immediate hypersensitivity reactions during infusion of intravenous vancomycin. The main question it aims to answer is: • Identifying novel biomarkers in blood that occur during infusion reaction Participants will: * Have allergy skin testing for vancomycin * Receive an infusion of vancomycin
Trial Details
NCT Number NCT07605806
Lead Sponsor Johns Hopkins University
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Conditions Healthy Volunteer, Hypersensitivity Reactions, Vancomycin
Enrollment 25 participants
Start Date 2026-05-21
Primary Completion 2027-05-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-05